載入...
Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s
The ability of cancer cells to ensure T-cell exclusion from the tumor microenvironment is a significant mechanism of resistance to anti-PD-1/PD-L1 therapy. Evidence indicates crucial roles of Batf3-dependent conventional type-1 dendritic cells (cDC1s) for inducing antitumor T-cell immunity; however,...
Na minha lista:
| 發表在: | Nat Commun |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7592056/ https://ncbi.nlm.nih.gov/pubmed/33110069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-020-19192-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|